Here's How Gilead Is Expanding Its Blockbuster-Potential Coronavirus Drug
Gilead Sciences said Wednesday it's testing an inhaled version of remdesivir in a bid to expand the coronavirus treatment to patients with non-hospitalized less severe Covid-19.